| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |